213 related articles for article (PubMed ID: 12611274)
21. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
Supuran CT; Scozzafava A; Briganti F; Clare BW
J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
[TBL] [Abstract][Full Text] [Related]
22. Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties.
Supuran CT; Briganti F; Scozzafava A; Ilies MA
J Enzyme Inhib; 2000; 15(4):335-56. PubMed ID: 10995066
[TBL] [Abstract][Full Text] [Related]
23. Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface.
Katz BA; Finer-Moore J; Mortezaei R; Rich DH; Stroud RM
Biochemistry; 1995 Jul; 34(26):8264-80. PubMed ID: 7599119
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
[TBL] [Abstract][Full Text] [Related]
25. Cyclotheonamides E2 and E3, new potent serine protease inhibitors from the marine sponge of the genus Theonella.
Nakao Y; Oku N; Matsunaga S; Fusetani N
J Nat Prod; 1998 May; 61(5):667-70. PubMed ID: 9599274
[TBL] [Abstract][Full Text] [Related]
26. 5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitor.
Finch H; Pegg NA; McLaren J; Lowdon A; Bolton R; Coote SJ; Dyer U; Montana JG; Owen MR; Dowle M; Buckley D; Ross BC; Campbell C; Dix C; Mooney C; Man-Tang C; Patel C
Bioorg Med Chem Lett; 1998 Nov; 8(21):2955-60. PubMed ID: 9873654
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of a ring-oxygenated variant of the 2-carboxy-6-hydroxyoctahydroindole core of aeruginosin 298-A from glucose.
Nie X; Wang G
J Org Chem; 2005 Oct; 70(22):8687-92. PubMed ID: 16238296
[TBL] [Abstract][Full Text] [Related]
28. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
[TBL] [Abstract][Full Text] [Related]
30. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
[TBL] [Abstract][Full Text] [Related]
31. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres.
St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM
Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986
[TBL] [Abstract][Full Text] [Related]
32. The synthesis of arginylfluoroalkanes, their inhibition of trypsin and blood-coagulation serine proteinases and their anticoagulant activity.
Ueda T; Kam CM; Powers JC
Biochem J; 1990 Jan; 265(2):539-45. PubMed ID: 2302184
[TBL] [Abstract][Full Text] [Related]
33. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
[TBL] [Abstract][Full Text] [Related]
34. [Synthetic serine proteinase inhibitors. 6. Inhibition of trypsin, plasmin and thrombin by phenylpyruvic acids containing various basic groups].
Markwardt F; Richter P; Stürzebecher J; Wagner G; Walsmann P
Acta Biol Med Ger; 1974; 33(1):K1-7. PubMed ID: 4279020
[No Abstract] [Full Text] [Related]
35. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues.
McConnell RM; York JL; Frizzell D; Ezell C
J Med Chem; 1993 Apr; 36(8):1084-9. PubMed ID: 8478905
[TBL] [Abstract][Full Text] [Related]
36. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based thrombin inhibitors: design, synthesis, and molecular docking of a new selective 2-oxo-2H-1-benzopyran derivative.
Frédérick R; Robert S; Charlier C; Wouters J; Masereel B; Pochet L
J Med Chem; 2007 Jul; 50(15):3645-50. PubMed ID: 17580844
[TBL] [Abstract][Full Text] [Related]
38. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
[TBL] [Abstract][Full Text] [Related]
39. Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.
Iwanowicz EJ; Kimball SD; Lin J; Lau W; Han WC; Wang TC; Roberts DG; Schumacher WA; Ogletree ML; Seiler SM
Bioorg Med Chem Lett; 2002 Nov; 12(21):3183-6. PubMed ID: 12372529
[TBL] [Abstract][Full Text] [Related]
40. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
Hays SJ; Caprathe BW; Gilmore JL; Amin N; Emmerling MR; Michael W; Nadimpalli R; Nath R; Raser KJ; Stafford D; Watson D; Wang K; Jaen JC
J Med Chem; 1998 Mar; 41(7):1060-7. PubMed ID: 9544206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
